Clinical Trials Logo

Clinical Trial Summary

The aim of this cross-sectional study is to evaluate the hidden blood loss in patients who undergo laparoendoscopic single-site radical hysterectomy with pelvic lymphadenectomy and identity its risk factors.


Clinical Trial Description

The electronic medical data of 105 patients who undergo laparoendoscopic single-site radical hysterectomy in the following year to treat cervical cancer will be analyzed retrospectively in this study. The amount of hidden blood loss will be calculated according to Gross's formula. And multiple linear regression analysis will be employed to identify its risk factors. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03626493
Study type Observational
Source Second Affiliated Hospital of Wenzhou Medical University
Contact Qiong ZHANG, Ph.D.
Phone 13587605820
Email joan_zhang2002@sina.com
Status Not yet recruiting
Phase
Start date September 1, 2022
Completion date September 1, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06289751 - Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer Phase 2
Recruiting NCT03963882 - NAC Followed by RH for the Treatment of LACC Phase 2
Completed NCT03570593 - Removal of Urinary Catheter After Radical Surgery N/A